Bio Elpida, your CMO for Autologous Anti-Cancer Vaccine
From Development to Logistics and Pharmaceutical Release

Specialized in cell therapy, Bio Elpida is involved in sub-contracting development of autologous anti-cancer vaccines.

Developments and clinical production of autologous anti-cancer vaccines are undergoing for various partners. In February 2015, one became public: the first therapeutic vaccine against glioblastoma to be used in a Phase II clinical trial in the US.

Inducing an immune response by re-injecting to a patient his/her own cells that have been treated

An autologous cell therapy is a therapy using cells from the patient him/herself (rather than those of a donor). Cells are sampled during a biopsy and treated in vitro (culture, irradiation, labelling…) before being re-injected to the very same person.

In the case of the autologous anti-cancer vaccine, tumour cells are sampled, treated and re-injected. Treated cells induce an immune response that will ultimately lead to the destruction of all cancer cells present within the patient.

Bio Elpida

Founded in 2009, Bio Elpida is a Biotechnology Contract Manufacturing Company specialised in the development and manufacturing of innovative cell therapies.

The expertise of the company covers 3 areas:
In these areas, Bio Elpida offers services that include:
Bio Elpida is the first French laboratory certified by the French Health Authorities (MSNA) as a Pharmaceutical Company and authorised to manufacture Active Pharmaceutical Ingredients for experimental biological pharmaceuticals.

Bio Elpida - 97 allée Alexandre Borodine - Bâtiment 5 Cèdre 1 - 69800 Saint Priest - FRANCE - Phone: +33 (0)4 78 47 02 70 - Mail: infos@bio-elpida.com
© Bio Elpida. All Rights Reserved - Legal information - Web site by: Estium-Concept
  • Your CMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  • Your CMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  • Your CMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  •  
  •  
  •